A Study of mRNA-based Influenza and SARS-CoV-2 (COVID-19) Multi-component Vaccines in Healthy Adults

NCT05827926 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

1758

Enrollment

INDUSTRY

Sponsor class

Conditions

SARS-CoV-2
Influenza

Interventions

BIOLOGICAL: Influenza Vaccine 1
BIOLOGICAL: mRNA-1083.1
BIOLOGICAL: mRNA-1083.2
BIOLOGICAL: mRNA-1083.3
BIOLOGICAL: Investigational Influenza Vaccine 1
BIOLOGICAL: Investigational COVID-19 Vaccine 1
BIOLOGICAL: COVID-19 Vaccine 1
BIOLOGICAL: Investigational Influenza Vaccine 2
BIOLOGICAL: Influenza Vaccine 2
BIOLOGICAL: mRNA-1083
BIOLOGICAL: Investigational COVID-19 Vaccine 2
BIOLOGICAL: COVID-19 Vaccine 2

Sponsor

ModernaTX, Inc.